A new trading day began on Friday, with Dyne Therapeutics Inc (NASDAQ: DYN) stock price down -4.12% from the previous day of trading, before settling in for the closing price of $23.55. DYN’s price has ranged from $6.36 to $35.68 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -59.45%. Meanwhile, its annual earnings per share averaged -8.03%. With a float of $109.62 million, this company’s outstanding shares have now reached $114.34 million.
The extent of productivity of a business whose workforce counts for 191 workers is very important to gauge.
Dyne Therapeutics Inc (DYN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 22.94%, while institutional ownership is 71.75%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.96 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.24% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Here are Dyne Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.86, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.53 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
The latest stats from [Dyne Therapeutics Inc, DYN] show that its last 5-days average volume of 4.98 million was superior to 2.64 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.59%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 85.71%, which indicates a significant increase from 78.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.02 in the past 14 days, which was higher than the 0.75 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.92, while its 200-day Moving Average is $12.38. Now, the first resistance to watch is $23.21. This is followed by the second major resistance level at $23.83. The third major resistance level sits at $24.32. If the price goes on to break the first support level at $22.09, it is likely to go to the next support level at $21.60. Assuming the price breaks the second support level, the third support level stands at $20.98.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
With a market capitalization of 3.21 billion, the company has a total of 142,264K Shares Outstanding. Currently, annual sales are 0 K while annual income is -317,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -110,860 K.
